谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

TransCon IL-2 Β/γ Alone or in Combination with Pembrolizumab, Standard of Care Chemotherapy or TransCon TLR7/8 Agonist in Advanced/metastatic Solid Tumors: Updated Results of the Phase 1/2 IL Believe Study.

Alexander Starodub, Sung-Bae Kim,Diwakar Davar,Oladapo O. Yeku,Andrew Graham Hill,John D. Powderly,Nashat Gabrail, Christian Krapp, Sibel Slavsky, Davis Y. Torrejon Castro,Stina Mui Singel, Vineet Kwatra

JOURNAL OF CLINICAL ONCOLOGY（2024）

引用 0|浏览5
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要